National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 388326

History of Changes from the VAERS Wayback Machine

First Appeared on 6/2/2010

VAERS ID: 388326
VAERS Form:
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:2009-03-16
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 2/4/2011

VAERS ID: 388326 Before After
VAERS Form:
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:2009-03-16 0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 6/14/2014

VAERS ID: 388326 Before After
VAERS Form:
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 2/14/2017

VAERS ID: 388326 Before After
VAERS Form:
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications:
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 4/14/2017

VAERS ID: 388326 Before After
VAERS Form:
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 9/14/2017

VAERS ID: 388326 Before After
VAERS Form:(blank) 1
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 0 1 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 2/14/2018

VAERS ID: 388326 Before After
VAERS Form:1
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 6/14/2018

VAERS ID: 388326 Before After
VAERS Form:1
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 8/14/2018

VAERS ID: 388326 Before After
VAERS Form:1
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.


Changed on 9/14/2018

VAERS ID: 388326 Before After
VAERS Form:1
Age:15.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:2009-01-15
Submitted:2010-05-14
Entered:2010-05-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Full blood count normal, Injection site erythema, Injection site induration, Oedema peripheral, Red blood cell sedimentation rate increased, Allergy to vaccine

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: Immunoglobulin E increased. Injection site erythema; injection site induration; injection site tenderness; Swelling arm~HPV (Gar
Other Medications: Unknown
Current Illness: Penicillin allergy; Sulfonamide allergy; Hypersensitivity
Preexisting Conditions: Vaccination adverse reaction
Allergies:
Diagnostic Lab Data: complete blood cell, normal; erythrocyte, $g31
CDC 'Split Type': WAES0904USA01138

Write-up: Information has been received from a physician concerning a female patient with penicillin allergy, sulfonamide allergy and cephalosporin allergy who on an unknown date was vaccinated with VARIVAX (Merck). Subsequently the patient experienced allergy to VARIVAX. The outcome of the adverse event was not reported. The patient experienced swelling of upper arm. Significant elevated levels of IgE and erythematous induration at site of injection while on therapy with GARDASIL, (WAES# 0902USA01435). Follow up information was received from a physician concerning the 15 year old female patient with penicillin allergy, sulfonamide allergy, allergy to cephalasporin and a history of adverse reaction to GARDASIL WAES#0902USA01435) who on 16-MAR-2009 was vaccinated intramuscularly in the left arm with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 15-JAN-2009 the patient developed 8.5 by 7.0 cm erythematous induration. Lab test showed that the patient''s complete blood cell count (CBC) was normal but her erythrocyte sedimentation rate was greater than 31. The patient recovered 26-JAN-2009. Additional information has been requested.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=388326&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166